Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / *W EXP 12/17/202
-
Total 13F shares
-
7,647,321
-
Share change
-
+40,052
-
Total reported value
-
$298,455
-
Price per share
-
$0.0380
-
Number of holders
-
22
-
Value change
-
-$13,607
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q1 2025
As of 31 Mar 2025 Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,647,321 shares of stock of the company.
Largest 10 holders included LMR Partners LLP, D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, ARISTEIA CAPITAL, L.L.C., PERCEPTIVE ADVISORS LLC, TORONTO DOMINION BANK, Bleichroeder LP, and Sculptor Capital LP.
This table shows 22 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.